Bank of New York Mellon Corp boosted its holdings in Sotera Health (NASDAQ:SHC - Free Report) by 45.1% in the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned 1,630,736 shares of the company's stock after buying an additional 507,147 shares during the period. Bank of New York Mellon Corp owned 0.58% of Sotera Health worth $22,308,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors have also made changes to their positions in SHC. Blue Trust Inc. lifted its holdings in shares of Sotera Health by 164.3% in the 4th quarter. Blue Trust Inc. now owns 1,834 shares of the company's stock valued at $25,000 after acquiring an additional 1,140 shares during the last quarter. True Wealth Design LLC purchased a new stake in Sotera Health in the 3rd quarter worth about $32,000. GAMMA Investing LLC increased its position in shares of Sotera Health by 37.5% during the fourth quarter. GAMMA Investing LLC now owns 4,109 shares of the company's stock worth $56,000 after acquiring an additional 1,121 shares during the period. Oak Thistle LLC purchased a new position in shares of Sotera Health during the fourth quarter worth approximately $222,000. Finally, First Citizens Bank & Trust Co. increased its position in shares of Sotera Health by 16.8% during the fourth quarter. First Citizens Bank & Trust Co. now owns 16,689 shares of the company's stock worth $228,000 after acquiring an additional 2,402 shares during the period. Institutional investors own 91.03% of the company's stock.
Sotera Health Stock Up 2.0 %
SHC traded up $0.23 during trading on Friday, hitting $11.59. The stock had a trading volume of 1,318,743 shares, compared to its average volume of 1,229,850. The company has a market capitalization of $3.29 billion, a PE ratio of 46.36 and a beta of 1.92. Sotera Health has a twelve month low of $10.71 and a twelve month high of $17.08. The company has a debt-to-equity ratio of 4.91, a quick ratio of 2.61 and a current ratio of 2.88. The stock has a 50 day simple moving average of $13.11 and a two-hundred day simple moving average of $14.30.
Wall Street Analyst Weigh In
A number of equities analysts have recently commented on the stock. Barclays reduced their target price on shares of Sotera Health from $17.00 to $16.00 and set an "overweight" rating on the stock in a research report on Friday, February 28th. The Goldman Sachs Group initiated coverage on shares of Sotera Health in a report on Friday, December 6th. They set a "neutral" rating and a $14.00 price objective on the stock. Finally, Royal Bank of Canada reissued an "outperform" rating and set a $17.00 price objective on shares of Sotera Health in a report on Thursday, November 21st. Two investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. According to MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and a consensus target price of $15.92.
View Our Latest Stock Report on Sotera Health
Sotera Health Company Profile
(
Free Report)
Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.
Further Reading
Before you consider Sotera Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sotera Health wasn't on the list.
While Sotera Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
